{"id":"https://openalex.org/W7204488926","doi":"https://doi.org/10.1038/s44321-026-00507-4","title":"A synthetic NKG2A engager enables long-term persistence of HLA-deficient allogeneic engineered Tregs","display_name":"A synthetic NKG2A engager enables long-term persistence of HLA-deficient allogeneic engineered Tregs","publication_year":2026,"publication_date":"2026-08-27","ids":{"openalex":"https://openalex.org/W7204488926","doi":"https://doi.org/10.1038/s44321-026-00507-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/42661001","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13658791"},"language":"en","primary_location":{"id":"doi:10.1038/s44321-026-00507-4","doi":"https://doi.org/10.1038/s44321-026-00507-4","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s44321-026-00507-4","pdf_url":"https://link.springer.com/content/pdf/10.1038/s44321-026-00507-4.pdf","source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1038/s44321-026-00507-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005020998","display_name":"Tingxi Guo","orcid":"https://orcid.org/0000-0003-2968-7187","observed_orcids":["https://orcid.org/0000-0003-2968-7187"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tingxi Guo","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA. tim.guo@gentibio.com"],"raw_orcid":"https://orcid.org/0000-0003-2968-7187","affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA. tim.guo@gentibio.com","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139678871","display_name":"Kaya R. Epstein","orcid":"https://orcid.org/0009-0001-9164-5159","observed_orcids":["https://orcid.org/0009-0001-9164-5159"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaya R Epstein","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":"https://orcid.org/0009-0001-9164-5159","affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033027592","display_name":"Maegan E. Hoover","orcid":"https://orcid.org/0009-0006-7280-179X","observed_orcids":["https://orcid.org/0009-0006-7280-179X"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maegan E Hoover","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":"https://orcid.org/0009-0006-7280-179X","affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082908691","display_name":"Nathan W. Zammit","orcid":"https://orcid.org/0000-0002-3694-2951","observed_orcids":["https://orcid.org/0000-0002-3694-2951"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan W Zammit","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034139871","display_name":"Jennifer Y. Yam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Y Yam","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018139025","display_name":"Scott Hussell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Hussell","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143813391","display_name":"Sophia Hernandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Hernandez","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032007634","display_name":"Abigail Doherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abigail Doherty","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077197953","display_name":"Payam Zarin","orcid":"https://orcid.org/0000-0001-9443-4405","observed_orcids":["https://orcid.org/0000-0001-9443-4405"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Payam Zarin","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002772047","display_name":"Martina Sassone\u2010Corsi","orcid":"https://orcid.org/0000-0002-4137-8371","observed_orcids":["https://orcid.org/0000-0002-4137-8371"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martina Sassone-Corsi","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000336280","display_name":"Lindsay Webb","orcid":"https://orcid.org/0000-0002-3204-568X","observed_orcids":["https://orcid.org/0000-0002-3204-568X"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsay Webb","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010581226","display_name":"Gene I. Uenishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gene I Uenishi","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110478756","display_name":"Thomas J. Wickham","orcid":"https://orcid.org/0009-0008-6812-7805","observed_orcids":["https://orcid.org/0009-0008-6812-7805"]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Wickham","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA","institution_ids":["https://openalex.org/I4405273489"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5132843777","display_name":"Christopher L. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273489","display_name":"GentiBio (United States)","ror":"https://ror.org/05wwbak83","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273489"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher L Moore","raw_affiliation_strings":["GentiBio Inc, Cambridge, MA, 02140, USA. chris.moore@gentibio.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GentiBio Inc, Cambridge, MA, 02140, USA. chris.moore@gentibio.com","institution_ids":["https://openalex.org/I4405273489"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005020998","https://openalex.org/A5132843777"],"corresponding_institution_ids":["https://openalex.org/I4405273489"],"apc_list":{"value":7990,"currency":"USD","value_usd":7990},"apc_paid":{"value":7990,"currency":"USD","value_usd":7990},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10","first_page":"3939","last_page":"3960"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.6958000063896179,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.6958000063896179,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.18970000743865967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.03500000014901161,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-cell-therapy","display_name":"allogeneic cell therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/hla-e","display_name":"HLA-E","score":0.7689999938011169},{"id":"https://openalex.org/keywords/nkg2c","display_name":"NKG2C","score":0.796999990940094},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.6700000166893005},{"id":"https://openalex.org/keywords/aav-gene-delivery","display_name":"AAV gene delivery","score":0.671999990940094},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.569100022315979},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.4912000000476837},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4674000144004822},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46720001101493835},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4553999900817871},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4422999918460846},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.43459999561309814},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40529999136924744},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3950999975204468},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38940000534057617},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.38109999895095825},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.36320000886917114},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3546000123023987},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.34940001368522644},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.314300000667572},{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.3052000105381012},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.29809999465942383},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.29280000925064087},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.2922999858856201},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.271699994802475},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.26499998569488525},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.26339998841285706},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2623000144958496}],"mesh":[{"descriptor_ui":"D000097625","descriptor_name":"HLA-E Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006680","descriptor_name":"HLA Antigens","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055654","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily C","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055654","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily C","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/s44321-026-00507-4","doi":"https://doi.org/10.1038/s44321-026-00507-4","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s44321-026-00507-4","pdf_url":"https://link.springer.com/content/pdf/10.1038/s44321-026-00507-4.pdf","source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13658791","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13658791/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13658791/pdf/44321_2026_Article_507.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Mol Med","raw_type":"Text"},{"id":"pmid:42661001","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42661001","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO molecular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b363ae02305845d6ab69544e96b16d66","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b363ae02305845d6ab69544e96b16d66","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EMBO Molecular Medicine, Vol 18, Iss 10, Pp 3939-3960 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s44321-026-00507-4","doi":"https://doi.org/10.1038/s44321-026-00507-4","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s44321-026-00507-4","pdf_url":"https://link.springer.com/content/pdf/10.1038/s44321-026-00507-4.pdf","source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204488926.pdf","grobid_xml":"https://content.openalex.org/works/W7204488926.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1938480622","https://openalex.org/W1973175840","https://openalex.org/W1973220478","https://openalex.org/W1977048108","https://openalex.org/W1978164777","https://openalex.org/W1979877646","https://openalex.org/W2039206013","https://openalex.org/W2039638023","https://openalex.org/W2090543914","https://openalex.org/W2099116621","https://openalex.org/W2108077848","https://openalex.org/W2116171543","https://openalex.org/W2323204318","https://openalex.org/W2402312308","https://openalex.org/W2486018727","https://openalex.org/W2593059553","https://openalex.org/W2613140751","https://openalex.org/W2616215756","https://openalex.org/W2772126867","https://openalex.org/W2795441690","https://openalex.org/W2911604931","https://openalex.org/W2912278137","https://openalex.org/W2934818991","https://openalex.org/W2981056570","https://openalex.org/W3017464623","https://openalex.org/W3026660164","https://openalex.org/W3028740982","https://openalex.org/W3041276616","https://openalex.org/W3091120769","https://openalex.org/W3118995603","https://openalex.org/W3160669634","https://openalex.org/W4224290067","https://openalex.org/W4283726599","https://openalex.org/W4293374782","https://openalex.org/W4297373422","https://openalex.org/W4302011928","https://openalex.org/W4306385439","https://openalex.org/W4318478930","https://openalex.org/W4368373774","https://openalex.org/W4375858821","https://openalex.org/W4388233496","https://openalex.org/W4390753124","https://openalex.org/W4391745500","https://openalex.org/W4393205384","https://openalex.org/W4395081799","https://openalex.org/W4396809668","https://openalex.org/W4399290685","https://openalex.org/W4400415576","https://openalex.org/W4403151870","https://openalex.org/W4403939847","https://openalex.org/W4406968170","https://openalex.org/W4408283632","https://openalex.org/W4409119107","https://openalex.org/W4412930202","https://openalex.org/W4413405935","https://openalex.org/W4413479448","https://openalex.org/W4414629938","https://openalex.org/W4415106991"],"related_works":["https://openalex.org/W4388233496","https://openalex.org/W3041276616","https://openalex.org/W3212534710","https://openalex.org/W4310099690","https://openalex.org/W4388221225","https://openalex.org/W4403151870","https://openalex.org/W4414629938","https://openalex.org/W4405043061","https://openalex.org/W4414947502","https://openalex.org/W4282946221"],"abstract_inverted_index":{"Allogeneic":[0],"cell":[1],"therapies":[2],"offer":[3],"a":[4,29,57,114,146],"scalable":[5],"and":[6,72,122,144],"off-the-shelf":[7,155],"alternative":[8],"to":[9,32,43,100,127,150],"the":[10,61,74,111,134],"autologous":[11],"approach,":[12],"but":[13],"immune":[14,128],"rejection,":[15],"particularly":[16],"by":[17],"natural":[18,62],"killer":[19],"(NK)":[20],"cells":[21,48,68,105],"following":[22],"human":[23],"leukocyte":[24],"antigen":[25],"(HLA)":[26],"ablation,":[27],"remains":[28],"major":[30],"barrier":[31],"their":[33],"persistence.":[34],"Here,":[35],"we":[36],"report":[37],"an":[38,139],"improved":[39,135],"synthetic":[40,141],"NKG2A":[41,136],"engager":[42,75,112,137],"selectively":[44],"inhibit":[45],"NKG2A\u207a":[46],"NK":[47,81,89],"while":[49,124],"avoiding":[50],"activation":[51],"of":[52,60,110,154],"NKG2C\u207a":[53],"subsets,":[54],"thereby":[55],"overcoming":[56],"key":[58],"limitation":[59],"ligand":[63],"HLA-E.":[64],"Engineered":[65],"regulatory":[66],"T":[67],"(EngTregs)":[69],"lacking":[70],"HLA":[71],"expressing":[73],"were":[76,106],"protected":[77],"from":[78],"in":[79],"vitro":[80],"cell-mediated":[82],"cytotoxicity":[83],"more":[84],"effectively":[85],"than":[86],"previously":[87],"reported":[88],"inhibitory":[90],"strategies.":[91],"In":[92],"humanized":[93],"mouse":[94],"models,":[95],"EngTregs":[96,118],"persisted":[97],"for":[98],"up":[99],"12":[101],"weeks,":[102],"whereas":[103],"unprotected":[104],"rapidly":[107],"rejected.":[108],"Incorporation":[109],"into":[113],"clinically":[115,147],"compatible":[116],"dual-AAV":[117],"preserved":[119],"Treg":[120],"identity":[121],"function":[123],"conferring":[125],"resistance":[126],"rejection.":[129],"Together,":[130],"these":[131],"findings":[132],"establish":[133],"as":[138],"effective":[140],"immune-evasion":[142],"strategy":[143],"provide":[145],"translatable":[148],"approach":[149],"enable":[151],"durable":[152],"persistence":[153],"EngTreg":[156],"therapies.":[157]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-08-28T00:00:00"}